title: Antiplatelet therapy in patients undergoing percutaneous coronary intervention: economic considerations.
abstract: Percutaneous coronary intervention (PCI) is one of the most common medical procedures performed for treatment of coronary artery disease. Antiplatelet medications as adjunctive therapy for PCI are used routinely, with indications for specific agents or their combinations varying depending on the clinical scenario. While the cost-effectiveness of well-established agents has been extensively studied, newer drugs have not been evaluated as thoroughly. In addition, the clinical application of some antiplatelet drugs has recently changed, thus making older studies of cost effectiveness less applicable to the current landscape of clinical practice. This article reviews cost-effectiveness considerations of antiplatelet therapies in the treatment of coronary artery disease in patients undergoing PCI. Aspirin, P2Y12 inhibitors including clopidogrel and the newer agents prasugrel and ticagrelor, as well as glycoprotein (GP) IIb/IIIa inhibitors, are discussed. Overall, the use of dual antiplatelet therapy with aspirin and a P2Y12 inhibitor in patients undergoing PCI improves ischaemic outcomes and appears to be cost effective. The few available studies suggest that the recently approved medications prasugrel and ticagrelor are cost-effective alternatives to clopidogrel. However, no direct comparison between these two newer agents is available. The indications for GP IIb/IIIa inhibitors have changed in the current PCI era, and there is a paucity of cost-effectiveness data for their use in contemporary care.
authors.forename: William S
authors.initials: WS
authors.lastname: Weintraub
authors.forename: Leonid
authors.initials: L
authors.lastname: Mandel
authors.forename: Sandra A
authors.initials: SA
authors.lastname: Weiss
mesh_terms: D001241:Aspirin / Q000008:administration & dosage / Q000191:economics / Q000627:therapeutic use; D003324:Coronary Artery Disease / Q000191:economics / Q000601:surgery*; D003362:Cost-Benefit Analysis; D004359:Drug Therapy, Combination; D006801:Humans; D062645:Percutaneous Coronary Intervention / Q000191:economics / Q000379:methods*; D010975:Platelet Aggregation Inhibitors / Q000008:administration & dosage / Q000191:economics / Q000627:therapeutic use*; D019039:Platelet Glycoprotein GPIIb-IIIa Complex / Q000037:antagonists & inhibitors; D016896:Treatment Outcome
chemical_list: D010975:Platelet Aggregation Inhibitors; D019039:Platelet Glycoprotein GPIIb-IIIa Complex; D001241:Aspirin
references.citation: J Am Coll Cardiol. 2011 Dec 6;58(24):e44-122
references.pmid: 22070834
references.citation: Am Heart J. 2006 Jan;151(1):219-27
references.pmid: 16368322
references.citation: Lancet. 1996 Nov 16;348(9038):1329-39
references.pmid: 8918275
references.citation: Eur Heart J. 2013 Jan;34(3):220-8
references.pmid: 22719022
references.citation: Circulation. 2011 Mar 1;123(8):933-44
references.pmid: 21262990
references.citation: Eur Heart J. 2002 Jan;23(1):50-8
references.pmid: 11741362
references.citation: Am Heart J. 2001 Mar;141(3):402-9
references.pmid: 11231437
references.citation: Eur Heart J. 2009 Nov;30(22):2705-13
references.pmid: 19875386
references.citation: BMJ. 2002 Jan 12;324(7329):71-86
references.pmid: 11786451
references.citation: Heart. 2012 Apr;98(7):544-51
references.pmid: 22313548
references.citation: N Engl J Med. 2001 Aug 16;345(7):494-502
references.pmid: 11519503
references.citation: Circulation. 2008 Jun 3;117(22):2875-83
references.pmid: 18506010
references.citation: JAMA. 2006 Jan 18;295(3):306-13
references.pmid: 16418466
references.citation: Int J Cardiol. 2009 Jul 10;135(3):353-60
references.pmid: 18586338
references.citation: J Intern Med. 2004 May;255(5):562-70
references.pmid: 15078498
references.citation: Ann Pharmacother. 1998 May;32(5):536-42
references.pmid: 9606473
references.citation: N Engl J Med. 2004 Jan 15;350(3):232-8
references.pmid: 14724302
references.citation: Lancet. 2009 Feb 28;373(9665):723-31
references.pmid: 19249633
references.citation: J Am Coll Cardiol. 2012 Aug 14;60(7):645-81
references.pmid: 22809746
references.citation: N Engl J Med. 2009 Dec 10;361(24):2318-29
references.pmid: 19915221
references.citation: Crit Pathw Cardiol. 2010 Mar;9(1):14-8
references.pmid: 20215905
references.citation: N Engl J Med. 2006 Apr 20;354(16):1706-17
references.pmid: 16531616
references.citation: Arch Intern Med. 2011 Feb 14;171(3):218-25
references.pmid: 21325111
references.citation: Eur J Cardiovasc Prev Rehabil. 2004 Dec;11(6):460-5
references.pmid: 15580055
references.citation: J Am Coll Cardiol. 2004 Nov 2;44(9):1792-800
references.pmid: 15519009
references.citation: Ann Pharmacother. 2005 Oct;39(10):1621-6
references.pmid: 16105872
references.citation: J Am Coll Cardiol. 2005 Feb 1;45(3):369-76
references.pmid: 15680714
references.citation: N Engl J Med. 2009 Sep 10;361(11):1045-57
references.pmid: 19717846
references.citation: Circulation. 2010 Jan 5;121(1):71-9
references.pmid: 20026770
references.citation: J Am Coll Cardiol. 2011 May 10;57(19):e215-367
references.pmid: 21545940
references.citation: Rev Esp Cardiol. 2005 Dec;58(12):1385-95
references.pmid: 16371197
references.citation: N Engl J Med. 2002 Jun 6;346(23):1800-6
references.pmid: 12050341
references.citation: Am J Health Syst Pharm. 2003 Jun 15;60(12):1251-6
references.pmid: 12845921
references.citation: Value Health. 2004 Jan-Feb;7(1):52-60
references.pmid: 14720130
references.citation: Circulation. 1998 Oct 20;98(16):1597-603
references.pmid: 9778323
references.citation: Nat Rev Cardiol. 2011 Aug 09;8(10):580-91
references.pmid: 21826073
references.citation: J Am Coll Cardiol. 2007 Nov 6;50(19):1852-6
references.pmid: 17980251
references.citation: Ann Intern Med. 2006 Mar 7;144(5):326-36
references.pmid: 16520473
references.citation: Curr Med Res Opin. 2008 Jul;24(7):2089-101
references.pmid: 18547464
references.citation: JAMA. 2005 Sep 14;294(10):1224-32
references.pmid: 16143698
references.citation: Am J Cardiol. 1996 May 15;77(12):1045-51
references.pmid: 8644655
references.citation: J Med Econ. 2012;15(1):166-74
references.pmid: 22066985
references.citation: N Engl J Med. 2008 May 22;358(21):2218-30
references.pmid: 18499566
references.citation: Value Health. 2011 Jan;14(1):24-33
references.pmid: 21211483
references.citation: N Engl J Med. 2001 Jun 21;344(25):1895-903
references.pmid: 11419426
references.citation: Arterioscler Thromb Vasc Biol. 2007 Jul;27(7):1500-10
references.pmid: 17510464
references.citation: N Engl J Med. 1996 Apr 25;334(17):1084-9
references.pmid: 8598866
references.citation: Lancet. 1997 May 17;349(9063):1429-35
references.pmid: 9164316
references.citation: N Engl J Med. 1998 Dec 3;339(23):1665-71
references.pmid: 9834303
references.citation: N Engl J Med. 2007 Nov 15;357(20):2001-15
references.pmid: 17982182
references.citation: N Engl J Med. 2005 Mar 24;352(12):1179-89
references.pmid: 15758000
references.citation: Lancet. 1998 Jul 11;352(9122):87-92
references.pmid: 9672272
references.citation: Eur J Health Econ. 2005 Dec;6(4):354-6, 358-62
references.pmid: 16267654
references.citation: JAMA. 2002 Nov 20;288(19):2411-20
references.pmid: 12435254
references.citation: Lancet. 2000 Dec 16;356(9247):2037-44
references.pmid: 11145489
references.citation: Circulation. 2009 Apr 14;119(14):1933-40
references.pmid: 19332467
references.citation: J Am Coll Cardiol. 2005 Mar 15;45(6):838-45
references.pmid: 15766816
references.citation: J Am Coll Cardiol. 2005 Sep 6;46(5):761-9
references.pmid: 16139122
references.citation: Stroke. 2005 Aug;36(8):1801-7
references.pmid: 16020759
references.citation: Clin Ther. 2007 Jun;29(6):1184-202
references.pmid: 17692733
references.citation: N Engl J Med. 2009 May 21;360(21):2176-90
references.pmid: 19332455
references.citation: Eur J Health Econ. 2007 Mar;8(1):51-7
references.pmid: 17186199
references.citation: N Engl J Med. 2012 Apr 19;366(16):1467-76
references.pmid: 22452338
references.citation: Circulation. 2004 Dec 14;110(24):3627-35
references.pmid: 15531766
references.citation: J Manag Care Pharm. 2007 May;13(4):326-36
references.pmid: 17506599
references.citation: Value Health. 2011 Jun;14(4):483-91
references.pmid: 21669373
references.citation: J Am Coll Cardiol. 2003 Dec 3;42(11):1879-85
references.pmid: 14662245
references.citation: Lancet. 2001 Aug 18;358(9281):527-33
references.pmid: 11520521
references.citation: N Engl J Med. 2002 Mar 28;346(13):957-66
references.pmid: 11919304
references.citation: JAMA. 2003 Feb 19;289(7):853-63
references.pmid: 12588269
references.citation: JAMA. 2007 Feb 14;297(6):591-602
references.pmid: 17299194
references.citation: Clin Ther. 2005 Jan;27(1):100-10
references.pmid: 15763611
references.citation: Pharmacotherapy. 2006 May;26(5):609-18
references.pmid: 16637790
references.citation: Lancet. 2005 Nov 5;366(9497):1607-21
references.pmid: 16271642
references.citation: Ann Intern Med. 2005 Feb 15;142(4):251-9
references.pmid: 15710958
references.citation: Can J Cardiol. 2007 Nov;23(13):1037-42
references.pmid: 17985004